{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T21:28:32Z","timestamp":1781558912079,"version":"3.54.5"},"reference-count":77,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2024,7,28]],"date-time":"2024-07-28T00:00:00Z","timestamp":1722124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Substance Use &amp; Addiction Journal"],"published-print":{"date-parts":[[2024,10]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>A recent National Institute on Drug Addiction Call to Action focused on expanding methadone treatment access for individuals with opioid use disorder (OUD). One research priority identified was optimal educational and support structures, including training to provide methadone across multiple healthcare settings (e.g., primary care, opioid treatment programs [OTPs], pharmacies) and healthcare workers (HCWs) (e.g., providers, pharmacists). This scoping review sought to better understand HCWs\u2019 knowledge, attitudes, and stigma as it relates to methadone provision.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Four databases (PubMed, PsycInfo, CINAHL, Web of Science) were searched for publications between 2010 and 2022 using keywords\u2014methadone, HCW, outpatient setting, knowledge, attitudes, and stigma, focusing on HCWs in general and pharmacists specifically.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>A total of 2,747 articles were identified and 14 met inclusion criteria for review. Settings included OTPs (n\u2009=\u20094), specialty addiction treatment clinics (n\u2009=\u20093), community pharmacies (n\u2009=\u20092), and multiple settings (n\u2009=\u20095). All articles (n\u2009=\u200914) examined methadone-related attitudes. Despite approval of methadone in 1972 to treat OUD, four articles illustrated continued methadone-related stigma held by HCWs. In response to COVID-19-related policy changes allowing methadone take-home flexibility, OTP clinicians expressed a range of attitudes concerning patient risk and potential program liability around diversion and misuse. One article assessing knowledge suggested that, even when most pharmacists correctly answered knowledge questions, a significant minority had misunderstandings that could undermine effective treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Given the current imbalance between methadone treatment demand and availability, there is a critical need to expand outpatient methadone services. Pharmacists partnering with OTPs represent a logical but underutilized access point. We identified key areas to improve HCWs methadone-related knowledge, attitudes, and stigma. Future research should explore the impact of outpatient pharmacy-OTP and other expansion services, and systematic training, education, and evaluation of methadone-related understanding, including assessment tools to measure knowledge, attitudes, and stigma.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/29767342241262115","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T07:14:44Z","timestamp":1767683684000},"page":"753-764","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":4,"title":["U.S. Healthcare Workers\u2019 Perspective of Outpatient Provision of Methadone: A Scoping Review"],"prefix":"10.1177","volume":"45","author":[{"given":"Sara E.","family":"Hernandez","sequence":"first","affiliation":[{"name":"Social and Administrative Sciences Division, School of Pharmacy, University of Wisconsin\u2014Madison, Madison, WI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron M.","family":"Gilson","sequence":"additional","affiliation":[{"name":"Social and Administrative Sciences Division, School of Pharmacy, University of Wisconsin\u2014Madison, Madison, WI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Te-Lien","family":"Ku","sequence":"additional","affiliation":[{"name":"Social and Administrative Sciences Division, School of Pharmacy, University of Wisconsin\u2014Madison, Madison, WI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Gassman","sequence":"additional","affiliation":[{"name":"Social and Administrative Sciences Division, School of Pharmacy, University of Wisconsin\u2014Madison, Madison, WI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3045-2414","authenticated-orcid":false,"suffix":"II","given":"James H.","family":"Ford","sequence":"additional","affiliation":[{"name":"Social and Administrative Sciences Division, School of Pharmacy, University of Wisconsin\u2014Madison, Madison, WI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2024,7,28]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7134a1"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2020.4402"},{"key":"e_1_3_3_4_2","article-title":"Opioid-related inpatient stays and emergency department visits by state, 2009\u20132014","author":"Weiss AJ","year":"2006","unstructured":"Weiss AJ, Elixhauser A, Barrett ML, Steiner CA, Bailey MK, O\u2019Malley L. Opioid-related inpatient stays and emergency department visits by state, 2009\u20132014. In: Healthcare Cost and Utilization Project (HCUP) Statistical Briefs. Agency for Healthcare Research and Quality (US); 2006.","journal-title":"Healthcare Cost and Utilization Project (HCUP) Statistical Briefs"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2018.06.008"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6709e1"},{"key":"e_1_3_3_7_2","unstructured":"Centers for Disease Control and Prevention. 2019 Annual Surveillance Report of Drug-Related Risks and Outcomes\u2014United States Surveillance Special Report. Centers for Disease Control and Prevention U.S. Department of Health and Human Services. Accessed December 12 2023. https:\/\/www.cdc.gov\/drugoverdose\/pdf\/pubs\/2019-cdc-drug-surveillancereport.pdf."},{"key":"e_1_3_3_8_2","unstructured":"Drug overdose deaths. Cdc.gov. Accessed December 12 2023. https:\/\/www.cdc.gov\/drugoverdose\/deaths\/index.html"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1612578"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1402780"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.7326\/M16-2953"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-publhealth-031914-122957"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(03)00055-3"},{"key":"e_1_3_3_14_2","unstructured":"Institute of Medicine (US) Committee on Federal Regulation of Methadone Treatment. Federal Regulation of Methadone Treatment. In: Rettig RA Yarmolinsky A eds. National Academies Press (US); 1995. Accessed November 20 2023. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK232108\/"},{"key":"e_1_3_3_15_2","volume-title":"Medications for Opioid Use Disorder Save Lives","author":"National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Health Sciences Policy; Committee on Medication-Assisted Treatment for Opioid Use Disorder","year":"2019","unstructured":"National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Health Sciences Policy; Committee on Medication-Assisted Treatment for Opioid Use Disorder. In: Mancher M, Leshner AI, eds. Medications for Opioid Use Disorder Save Lives. National Academies Press (US); 2019."},{"key":"e_1_3_3_16_2","unstructured":"Methadone. Samhsa.gov. Accessed December 12 2023. https:\/\/www.samhsa.gov\/medications-substance-use-disorders\/medications-counseling-related-conditions\/methadone"},{"key":"e_1_3_3_17_2","unstructured":"Medications counseling and related conditions. Samhsa.gov. Accessed December 12 2023. https:\/\/www.samhsa.gov\/medications-substance-use-disorders\/medications-counseling-related-conditions"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002209.pub2"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2005.02.007"},{"key":"e_1_3_3_20_2","volume-title":"Methadone Treatment for Opioid Use Disorder: Improving Access Through Regulatory and Legal Change: Proceedings of a Workshop","author":"National Academies of Sciences, Engineering, and Medicine; Action Collaborative on Countering the U.S. Opioid Epidemic; Health and Medicine Division; Board on Health Care Services; Board on Health Sciences Policy","year":"2022","unstructured":"National Academies of Sciences, Engineering, and Medicine; Action Collaborative on Countering the U.S. Opioid Epidemic; Health and Medicine Division; Board on Health Care Services; Board on Health Sciences Policy. In: Stroud C, Posey Norris SM, Bain L, eds. Methadone Treatment for Opioid Use Disorder: Improving Access Through Regulatory and Legal Change: Proceedings of a Workshop. National Academies Press (US); 2022."},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13746"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12396"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6963-11-175"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11469-012-9402-5"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1177\/1178221816685087"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2022.108721"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2022.108918"},{"key":"e_1_3_3_28_2","author":"Goffman E.","year":"1963","unstructured":"Goffman E. Stigma: notes on the Management of Spoiled Identity. Prentice Hall; 1963.","journal-title":"Stigma: notes on the Management of Spoiled Identity"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/jep.13684"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.dadr.2023.100138"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10597-017-0218-4"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.josat.2023.209051"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2022.108747"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.josat.2023.209153"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1080\/00952990.2019.1694536"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2020.102704"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2013.10.006"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.josat.2023.209055"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.3109\/14659891.2012.734539"},{"key":"e_1_3_3_40_2","unstructured":"Congressional Research Service. Location of Medication-Assisted Treatment for Opioid Addiction: In Brief. Accessed December 12 2023. https:\/\/crsreports.congress.gov\/product\/pdf\/R\/R45782"},{"key":"e_1_3_3_41_2","unstructured":"Opioid Treatment Program Directory. Samhsa.gov. Accessed December 12 2023. https:\/\/dpt2.samhsa.gov\/treatment\/directory.aspx"},{"key":"e_1_3_3_42_2","unstructured":"U.S. Census Bureau QuickFacts: United States Accessed August 23 2023. https:\/\/www.census.gov\/quickfacts\/fact\/table\/US\/PST045222"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.12562"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2020.1624"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-020-05721-5"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0183172"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2020.107968"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.1111\/add.15641"},{"key":"e_1_3_3_49_2","doi-asserted-by":"publisher","DOI":"10.1080\/08897077.2021.1975344"},{"key":"e_1_3_3_50_2","doi-asserted-by":"publisher","DOI":"10.1111\/ajad.13068"},{"key":"e_1_3_3_51_2","doi-asserted-by":"publisher","DOI":"10.7326\/M18-0850"},{"key":"e_1_3_3_52_2","doi-asserted-by":"publisher","DOI":"10.1080\/00981389.2012.725457"},{"key":"e_1_3_3_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.japh.2020.01.001"},{"key":"e_1_3_3_54_2","unstructured":"Substance Abuse and Mental Health Services Administration. Medications for Opioid Use Disorder. Treatment Improvement Protocol (TIP) Series 63 Publication No. PEP21-02-01-002. Rockville MD: substance Abuse and Mental Health Services Administration 2021. https:\/\/store.samhsa.gov\/product\/TIP-63-Medications-for-Opioid-Use-Disorder-Full-Document\/PEP21-02-01-002"},{"key":"e_1_3_3_55_2","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000166"},{"key":"e_1_3_3_56_2","unstructured":"Lexicomp: evidence-Based Drug Referential Content. Accessed August 23 2023. https:\/\/www.wolterskluwer.com\/en\/solutions\/lexicomp"},{"key":"e_1_3_3_57_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11414-018-9616-9"},{"key":"e_1_3_3_58_2","doi-asserted-by":"publisher","DOI":"10.1080\/08897077.2020.1846149"},{"key":"e_1_3_3_59_2","doi-asserted-by":"publisher","DOI":"10.1080\/08897077.2021.1986768"},{"key":"e_1_3_3_60_2","doi-asserted-by":"publisher","DOI":"10.1080\/15332640.2014.976803"},{"key":"e_1_3_3_61_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2021.108288"},{"key":"e_1_3_3_62_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.109100"},{"key":"e_1_3_3_63_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11414-018-9603-1"},{"key":"e_1_3_3_64_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2020.108191"},{"key":"e_1_3_3_65_2","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2014.921745"},{"key":"e_1_3_3_66_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13011-020-00312-3"},{"key":"e_1_3_3_67_2","doi-asserted-by":"publisher","DOI":"10.1080\/10550887.2015.1059225"},{"key":"e_1_3_3_68_2","doi-asserted-by":"publisher","DOI":"10.1080\/08897077.2022.2060423"},{"key":"e_1_3_3_69_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-137-8-200210150-00014"},{"key":"e_1_3_3_70_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-002-0041-6"},{"key":"e_1_3_3_71_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.46971"},{"key":"e_1_3_3_72_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13722-023-00366-1"},{"key":"e_1_3_3_73_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0376-8716(98)00047-7"},{"key":"e_1_3_3_74_2","doi-asserted-by":"publisher","DOI":"10.1111\/add.14799"},{"key":"e_1_3_3_75_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13011-023-00563-w"},{"key":"e_1_3_3_76_2","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0b013e318166af74"},{"key":"e_1_3_3_77_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n784"},{"key":"e_1_3_3_78_2","unstructured":"Federal guidelines for opioid treatment programs. Samhsa.gov. Accessed December 12 2023. https:\/\/www.samhsa.gov\/resource\/ebp\/federal-guidelines-opioid-treatment-programs"}],"container-title":["Substance Use &amp; Addiction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/29767342241262115","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/29767342241262115","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/29767342241262115","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T01:49:59Z","timestamp":1777600199000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/29767342241262115"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,28]]},"references-count":77,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["10.1177\/29767342241262115"],"URL":"https:\/\/doi.org\/10.1177\/29767342241262115","relation":{},"ISSN":["2976-7342","2976-7350"],"issn-type":[{"value":"2976-7342","type":"print"},{"value":"2976-7350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,28]]}}}